Last reviewed · How we verify
Diphenhydramine hydrochloride or alternative antihistamine — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Diphenhydramine hydrochloride or alternative antihistamine (Diphenhydramine hydrochloride or alternative antihistamine) — Hoffmann-La Roche.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Diphenhydramine hydrochloride or alternative antihistamine TARGET | Diphenhydramine hydrochloride or alternative antihistamine | Hoffmann-La Roche | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Diphenhydramine hydrochloride or alternative antihistamine CI watch — RSS
- Diphenhydramine hydrochloride or alternative antihistamine CI watch — Atom
- Diphenhydramine hydrochloride or alternative antihistamine CI watch — JSON
- Diphenhydramine hydrochloride or alternative antihistamine alone — RSS
Cite this brief
Drug Landscape (2026). Diphenhydramine hydrochloride or alternative antihistamine — Competitive Intelligence Brief. https://druglandscape.com/ci/diphenhydramine-hydrochloride-or-alternative-antihistamine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab